Travere Therapeutics Inc (TVTX)

Jul 27, 2026

Travere Therapeutics Inc (TVTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026

Jul 27, 2026

Travere Therapeutics Inc (TVTX) Cash Flow - TradingKey

Jul 27, 2026

Jul 27, 2026

Investigation launched into Travere Therapeutics' officers for possible self-dealing breaches - Pluang

Jul 27, 2026

Jul 27, 2026

TVTX|Travere Therapeutics Inc|Price:56.680|Chg%:-0.680 - TradingKey

Jul 27, 2026

Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics Inc (TVTX) Institutional Confidence - TradingKey

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics (NASDAQ:TVTX): High Growth Momentum Stock with Breakout Setup - ChartMill

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics Inc (TVTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics Inc (TVTX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics Inc (TVTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 25, 2026

Jul 25, 2026

Travere Therapeutics Wins Much-Awaited Approval For Drug In Rare Kidney Disease - Stocktwits

Jul 25, 2026

Jul 23, 2026

Travere Therapeutics Inc (TVTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 23, 2026

Jul 23, 2026

TVTX Stock On Track To Hit Near 20-Year Highs After Filspari Becomes The Only Approved FSGS Treatment - Stocktwits

Jul 23, 2026

Jul 22, 2026

Travere Therapeutics (TVTX) Gets a Buy from Guggenheim - The Globe and Mail

Jul 22, 2026

Jul 22, 2026

Travere Therapeutics, Inc. Stock 12‑Month Price Target Raised to $58.71, Implies 4% Upside - TradingView

Jul 22, 2026

Jul 22, 2026

TVTX|Travere Therapeutics Inc|Price:56.670|Chg%:+0.410 - TradingKey

Jul 22, 2026

Jul 21, 2026

Why (TVTX) Price Action Is Critical for Tactical Trading - Stock Traders Daily

Jul 21, 2026

Jul 21, 2026

ETFs Investing in Travere Therapeutics, Inc. Stocks - TradingView

Jul 21, 2026

Jul 20, 2026

RTRX5376243 Bond Profile — Key Metrics - TradingView

Jul 20, 2026

Jul 20, 2026

Exploring High Growth Tech Stocks In The US For July 2026 - simplywall.st

Jul 20, 2026

Jul 18, 2026

TVTX, LGND Stocks In Spotlight Ahead Of Monday’s FDA Call On Kidney Drug Filspari - Stocktwits

Jul 18, 2026

Jul 16, 2026

Law firm probes Travere Therapeutics officers f... - Pluang

Jul 16, 2026

Jul 16, 2026

Kuehn Law Encourages Investors of Travere Therapeutics, Inc. to Contact Law Firm - GlobeNewswire Inc.

Jul 16, 2026

Jul 14, 2026

Analysts Offer Insights on Healthcare Companies: Pediatrix Medical Group (MD) and Travere Therapeutics (TVTX) - The Globe and Mail

Jul 14, 2026

Jul 13, 2026

RTRX6388605 Bond Risk Profile - TradingView

Jul 13, 2026

Jul 13, 2026

RTRX6388605 Bond Profile — Key Metrics - TradingView

Jul 13, 2026

Jul 10, 2026

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 10, 2026

Jul 10, 2026

Travere Therapeutics Accounting Chief Sandra Calvin to Retire in 2027 - Moomoo

Jul 10, 2026

Jul 10, 2026

Travere Therapeutics plans accounting leadership transition in 2026 - The Globe and Mail

Jul 10, 2026

Jul 09, 2026

Travere Therapeutics, Inc. Files Form 8-K with SEC: Key Details on Company and Stock Listing for July 2026 - Minichart

Jul 09, 2026

Jul 09, 2026

Sandra Calvin to Retire as Travere Therapeutics CAO; John Torell Named Successor - TradingView

Jul 09, 2026

Jul 09, 2026

Travere Therapeutics (NASDAQ: TVTX) plans CAO transition as Sandra Calvin retires - Stock Titan

Jul 09, 2026

Jul 08, 2026

Travere Therapeutics Inc. (TVTX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com

Jul 08, 2026

Jul 08, 2026

US FDA approves Vera's kidney disease drug - Reuters

Jul 08, 2026

Jul 08, 2026

Everest Medicines Announces Close of Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib - Macau Business

Jul 08, 2026

Jul 07, 2026

Travere Therapeutics, Inc. Actuals & Estimates (NASDAQ:TVTX) - TradingView

Jul 07, 2026

Jul 07, 2026

Travere Therapeutics Receives Notice of Allowance from the U.S. Patent and Trademark Office for U.S. Patent Application Directed to Certain Methods of Using FILSPARI® (sparsentan) in IgA Nephropathy - AOL.com

Jul 07, 2026

Jul 07, 2026

Travere Therapeutics Presents Long-Term Open-Label Extension Data from the Phase 3 DUPLEX Study at the 63rd European Renal Association (ERA) 2026 Congress - AOL.com

Jul 07, 2026

Jul 07, 2026

Will Travere’s Removal From Key Russell Value Indices Change Travere Therapeutics' (TVTX) Narrative? - simplywall.st

Jul 07, 2026

Jul 03, 2026

Travere Therapeutics: Filspari Is Becoming A Rare Kidney Disease Platform (NASDAQ:TVTX) - Seeking Alpha

Jul 03, 2026

Jun 30, 2026

Travere Therapeutics Receives Notice of Allowance from the U.S. P - The National Law Review

Jun 30, 2026

Jun 29, 2026

Travere Therapeutics, Inc.(NasdaqGM: TVTX) dropped from Russell 2000 Value Benchmark - marketscreener.com

Jun 29, 2026

Jun 29, 2026

Understanding Momentum Shifts in (TVTX) - Stock Traders Daily

Jun 29, 2026

Jun 28, 2026

Travere Therapeutics, Inc.(NasdaqGM:TVTX) dropped from Russell Small Cap Comp Value Benchmark - marketscreener.com

Jun 28, 2026

Jun 28, 2026

Enterprise value to revenue forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 28, 2026

Jun 28, 2026

Price to earnings forward of Travere Therapeutics, Inc. – NASDAQ:TVTX - TradingView

Jun 28, 2026